
| Serial Number | 98303149 | 
| Word Mark | OPELLA | 
| Filing Date | Thursday, December 7, 2023 | 
| Status | 730 - FIRST EXTENSION - GRANTED | 
| Status Date | Thursday, February 27, 2025 | 
| Registration Number | 0000000 | 
| Registration Date | NOT AVAILABLE | 
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form | 
| Published for Opposition Date | Tuesday, July 23, 2024 | 
| Goods and Services | Business consulting services for consumers in the fields of pharmaceutical products; providing consumer information to consumers regarding products in the field of pharmaceuticals; advertising and marketing services; providing commercial information to customers on pharmaceutical products; administration and business management in the field of health; distribution of printed promotional materials in the health field; promotional services and public awareness campaigns in the field of health. | 
| Goods and Services | Scientific and technological services, namely, pharmaceutical research; design and development of software and databases in the field of health; medical and scientific research, namely, conducting clinical trials for others; providing medical and scientific research information. | 
| International Class | 035 - Advertising; business management; business administration; office functions. | 
| US Class Codes | 100, 101, 102 | 
| Class Status Code | 6 - Active | 
| Class Status Date | Thursday, December 7, 2023 | 
| Primary Code | 035 | 
| First Use Anywhere Date | NOT AVAILABLE | 
| First Use In Commerce Date | NOT AVAILABLE | 
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. | 
| US Class Codes | 100, 101 | 
| Class Status Code | 6 - Active | 
| Class Status Date | Thursday, December 7, 2023 | 
| Primary Code | 042 | 
| First Use Anywhere Date | NOT AVAILABLE | 
| First Use In Commerce Date | NOT AVAILABLE | 
| Party Name | Opella Healthcare Switzerland AG | 
| Party Type | 20 - Owner at Publication | 
| Legal Entity Type | 33 - NOT AVAILABLE | 
| Address | Rotkreuz 6343 CH  | 
| Party Name | Opella Healthcare Switzerland AG | 
| Party Type | 10 - Original Applicant | 
| Legal Entity Type | 33 - NOT AVAILABLE | 
| Address | Rotkreuz 6343 CH  | 
| Event Date | Event Description | 
| Thursday, December 7, 2023 | NEW APPLICATION ENTERED | 
| Tuesday, March 5, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 
| Wednesday, June 12, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 
| Friday, June 14, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE | 
| Saturday, June 15, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED | 
| Tuesday, June 11, 2024 | ASSIGNED TO EXAMINER | 
| Wednesday, June 12, 2024 | NON-FINAL ACTION WRITTEN | 
| Wednesday, June 12, 2024 | NON-FINAL ACTION E-MAILED | 
| Friday, June 14, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 
| Monday, June 17, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER | 
| Tuesday, July 23, 2024 | PUBLISHED FOR OPPOSITION | 
| Wednesday, July 3, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 
| Thursday, February 27, 2025 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 
| Thursday, February 27, 2025 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | 
| Thursday, February 27, 2025 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 
| Thursday, February 27, 2025 | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | 
| Tuesday, July 23, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 
| Tuesday, September 17, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 
| Thursday, February 27, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED | 
| Thursday, February 27, 2025 | SOU TEAS EXTENSION RECEIVED | 
| Thursday, February 27, 2025 | SOU EXTENSION 1 FILED | 
| Friday, February 28, 2025 | SOU EXTENSION 1 GRANTED | 
| Friday, February 28, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 
| Wednesday, September 3, 2025 | TEAS STATEMENT OF USE RECEIVED |